Logo

Schering-Plough Signs on for Pharsight s Drug Software

Aug 14, 2002

NEW YORK, Aug. 14 - The Schering-Plough Research Institute will use Pharsight's Knowledgebase software for drug development, Pharsight said today.

 

The software organizes pharmacokinetic data.

The Schering-Plough Research Institute, based in Kenilworth, NJ, focuses on drug discovery and development. Mountain View, Calif.-based Pharsight develops software for drug development, clinical trials and market modeling.

Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.